FrancophonIA/ELRC3.0 huggingface dataset:
English: After initial systemic exposure, ibandronic acid rapidly binds to bone or is excreted into urine.
Slovenian: Po prvotni sistemski izpostavljenosti se ibandronska kislina hitro veže v kostno tkivo ali pa se izloči skozi ledvice.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Druga zdravila in zdravilo IasibonObvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: The primary endpoint of the trial was the skeletal morbidity period rate (SMPR).
Slovenian: Primarni cilj raziskave je bil stopnja hitrosti obolevnosti okostja (SMPR - skeletal morbidity period rate).
English: This could be a sign of an ulcer of the first section of the bowel (duodenum)
Slovenian: Te so lahko znak, da razjeda v začetnem delu črevesa (dvanajstniku)
English: Appropriate medical support and monitoring measures should be readily available when Iasibon intravenous injection is administered.
Slovenian: Pri dajanju intravenske injekcije zdravila Iasibon mora biti na voljo ustrezna medicinska podpora in nadzor.
English: If you have moderate kidney problems, your doctor may reduce your dose to one tablet every other day.
Slovenian: Če imate blage težave z ledvicami, vam bo morda vaš zdravnik zmanjšal odmerek na eno tableto vsak drugi dan.
English: Only clear solution without particles should be used.
Slovenian: Uporabi se lahko samo bistra raztopina, brez delcev.
English: Biotransformation There is no evidence that ibandronic acid is metabolized in animals or humans.
Slovenian: Biotransformacija Ni dokazov, da bi se ibandronska kislina pri ljudeh in živalih presnavljala.
English: • hair loss
Slovenian: • izguba las,
English: Less frequently, decrease in serum calcium below normal range (hypocalcaemia) is reported.
Slovenian: Manj pogosto poročajoo znižanju serumskega kalcija pod spodnjo mejo normale (hipokalciemija).
English: The unabsorbed fraction of ibandronic acid is eliminated unchanged in the faeces.
Slovenian: Neabsorbirani delež ibandronske kisline se izloči nespremenjen s fecesom.
English: There was also a 38% reduction in the risk of developing an SRE for Ibandronate treated patients when compared with placebo (relative risk 0.62, p=0.003).
Slovenian: V primerjavi s placebom je bilo tveganje za nastanek SRE pri bolnikih, zdravljenih z ibandronsko kislino, za 38 % manjše (relativno tveganje 0,62, p = 0,003).
English: Further, as protein binding of ibandronic acid is approximately 87% at therapeutic concentrations, hypoproteinaemia in severe liver disease is unlikely to lead to clinically significant increases in free plasma concentration.
Slovenian: Vezava ibandronske kisline na beljakovine pri terapevtskih koncentracijah je približno 87-%, zato hipoproteinemija pri bolnikih s hudo jetrno okvaro verjetno ne povzroča klinično značilnih povišanj prostih plazemskih koncentracij.
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 °C, unless reconstitution has taken place in controlled and validated aseptic conditions.
Slovenian: V normalnih razmerah naj zdravila ne bi shranjevali dlje kot 24 ur pri 2 do 8 °C, razen če je bila priprava opravljena v nadzorovanih in validiranih aseptičnih pogojih.
English: ≥50 CLcr <80 6 mg (6 ml of concentrate for solution for infusion)
Slovenian: ≥50 CLcr < 80 6 mg (6 ml koncentrata za raztopino za infundiranje)
English: For patients who develop osteonecrosis of the jaw while on bisphosphonate therapy, dental surgery may exacerbate the condition.
Slovenian: Pri bolnikih, pri katerih se med zdravljenjem z difosfonati pojavi osteonekroza čeljustnic, lahko zobne operacije stanje poslabšajo.
English: Clinically relevant hypocalcaemia should be corrected by intravenous administration of calcium gluconate.
Slovenian: Klinično pomembno hipokalciemijo je treba popraviti z intravenskim dajanjem kalcijevega glukonata.
English: Ibandronate 50 mg n=287
Slovenian: Ibandronska kislina 50 mg n = 287
English: • headache, feeling dizzy or feeling weak
Slovenian: • glavobol, vrtoglavica ali občutek šibkosti,
English: This is because the medicine will only work if it is taken all the time.
Slovenian: Zdravilo Iasibon jemljite tako dolgo, kot vam je naročil zdravnik, kajti zdravilo bo delovalo le, če ga boste jemali ves čas.
English: • sleep problems, feeling anxious, emotional instability, or mood swings
Slovenian: • težave s spanjem, občutek zaskrbljenosti, čustvena nestabilnost ali menjava razpoloženja, • kožni izpuščaj,
English: • a type of antibiotic injection called “aminoglycoside” such as gentamicin.
Slovenian: • antibiotik v obliki injekcije iz skupine aminoglikozidov, kot je gentamicin.
English: This leaflet was last revised in {MM/YYYY}
Slovenian: Navodilo je bilo nazadnje revidiranoodobreno
English: Patients with hepatic impairment (see section 4.2)
Slovenian: Bolniki z jetrno okvaro (glejte poglavje 4.2)
English: Stevens-Johnson Syndrome†, Erythema Multiforme†, Dermatitis Bullous†
Slovenian: StevensJohnsonov sindrom†, multiformni eritem†, bulozni dermatitis†
English: Therefore, Iasibon should not be used during pregnancy.
Slovenian: Zato se zdravila Iasibon med nosečnostjo ne sme uporabljati.
English: Female patients with breast cancer and radiologically confirmed bone metastases were randomised to receive placebo (158 patients) or 6 mg Ibandronate (154 patients).
Slovenian: Bolnice z rakom dojke in radiološko potrjenimi metastazami v kosteh so prejemale placebo (158 bolnic) ali 6 mg ibandronske kisline (154 bolnic).
English: Exposure to ibandronic acid in patients with various degrees of renal impairment is related to creatinine clearance (CLcr).
Slovenian: Izpostavljenost ibandronski kislini pri bolnikih z različnimi stopnjami ledvične okvare je povezana s kreatininskim očistkom (CLcr).
English: There are no data available characterising the use of a shorter infusion time in patients with creatinine clearance below 50 ml/min.
Slovenian: Podatkov, ki bi označevali uporabo krajšega časa infuzije pri bolnikih z očistkom kreatinina pod 50 ml/min, ni na voljo.
English: • tooth problems.
Slovenian: • kožne težave, • težave z zobmi.
English: • heart and circulatory problems (including palpitations, heart attack, hypertension (high blood pressure) and varicose veins)
Slovenian: • težave s srcem in obtočili (vključno s palpitacijami, srčno kapjo, hipertenzijo (zvišanim krvnim tlakom) in krčnimi žilami),
English: ≥30 CLcr <50 4 mg (4 ml of concentrate for solution for infusion)
Slovenian: ≥30 CLcr < 50 4 mg (4 ml koncentrata za raztopino za infundiranje)
English: However, early plasma levels fall quickly, reaching 10% of peak values within 3 and 8 hours after intravenous or oral administration respectively.
Slovenian: Zgodnje plazemske koncentracije hitro padejo, 10 % največje vrednosti dosežejo 3 ure po intravenskem in 8 ur po peroralnem dajanju.
English: For patients with severe renal impairment (CLcr <30 mL/min) the recommended dose is one 50 mg film-coated tablet once weekly.
Slovenian: Pri bolnikih s hudo ledvično okvaro (CLcr < 30 ml/min) je priporočeni odmerek ena 50 mg filmsko obložena tableta enkrat na teden.
English: What Iasibon looks like and contents of the pack Iasibon is a colourless, clear solution.
Slovenian: Izgled zdravila Iasibon in vsebina pakiranja Zdravilo Iasibon je brezbarvna, bistra raztopina.
English: Female patients with breast cancer and radiologically confirmed bone metastases were randomised to receive placebo (277 patients) or 50 mg Ibandronate (287 patients).
Slovenian: Bolnice z rakom dojke in radiološko potrjenimi metastazami v kosteh so prejemale placebo (277 bolnic) ali 50 mg ibandronske kisline (278 bolnic).
English: • It is given as an infusion into your vein
Slovenian: • Aplicira se v obliki infuzije v veno.
English: Subjects with severe renal impairment (CLcr ≤ 30 mL/min) receiving oral administration of 10 mg ibandronic acid daily for 21 days, had 2-3 fold higher plasma concentrations than subjects with normal renal function (CLcr ≥80 mL/min).
Slovenian: Bolniki s hudo motnjo ledvičnega delovanja (CLcr ≤ 30 ml/min), ki so peroralno prejemali 10 mg ibandronske kisline na dan 21 dni, so imeli 2 do 3-krat višje plazemske koncentracije kot osebe z normalno ledvično funkcijo (CLcr ≥ 80 ml/min).
English: Iasibon is indicated in adults for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
Slovenian: Zdravilo Iasibon je indiciran pri odraslih za preprečevanje z okostjem povezanih dogodkov (patološke frakture, zapleti, pri katerih je potrebno obsevanje ali kirurški poseg) pri bolnikih z rakom dojke in metastazami v kosteh.
English: • high levels of urea or high levels of parathyroid hormone in your blood.
Slovenian: • visoke koncentracije sečnine ali visoke koncentracije obščitniškega hormona v krvi.
English: - Patients should not lie down for 60 minutes after taking Iasibon.
Slovenian: - Po zaužitju zdravila Iasibon bolniki 60 minut ne smejo leči.
English: Dose: Treatment of tumour-induced hypercalcaemia Iasibon is usually administered in a hospital setting.
Slovenian: Odmerjanje: zdravljenje tumorsko povzročene hiperkalciemije Dajanje zdravila Iasibon običajno poteka v bolnišnici.
English: What Iasibon looks like and contents of the pack The film-coated tablets are white, round biconvex tablets supplied in Polyamide/Al/PVC - Aluminum foil blister.
Slovenian: Filmsko obložene tablete so bele, okrogle, bikonveksne tablete na voljo v poliamid/Al/PVCaluminijasto folijo.
English: • Stay upright (sitting or standing) position while taking your tablet and for the next hour (60 minutes).
Slovenian: • med jemanjem tablete in še naslednjo uro (60 minut) ostanete v pokončnem položaju (stoje ali sede).
English: Urinary concentrations of the bone resorption marker CTx (C-terminal telopeptide released from Type I collagen) were significantly reduced in the Ibandronate group compared to placebo.
Slovenian: Koncentracije označevalca resorpcije kosti CTx (C-terminalni telopeptid, ki se sprosti s kolagena tipa I) v seču so bile v skupini zdravljeni z ibandronsko kislino v primerjavi s placebom značilno znižane.
English: Ibandronate 6 mg n=154
Slovenian: Ibandronska kislina 6 mg n = 154
English: • itching or tingling skin (paraesthesia)
Slovenian: • srbenje ali ščemenje kože (parestezija),
English: Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Iasibon is given to patients with active upper gastrointestinal problems (e.g. known Barrett's oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Slovenian: Zaradi možnega draženja in poslabšanja osnovne bolezni je pri dajanju zdravila Iasibon bolnikom z aktivnimi težavami v zgornjem delu prebavne cevi (npr. Barrettov požiralnik, disfagija, druge bolezni ezofagusa, gastritis, duodenitis ali razjede) potrebna previdnost.
English: The medicine should be administered as an infusion in your vein over two hours.
Slovenian: Zdravilo se daje v obliki infuzije v veno, ki traja dve uri.
English: You may have early signs of a possible unusual fracture of the thigh bone.
Slovenian: To so lahko zgodnji znaki možnega netipičnega zloma stegnenice.
English: Only clear solutions without particles should be used.
Slovenian: Uporabljamo lahko le bistre raztopine brez delcev.
English: Do not chew, suck or crush the tablet.
Slovenian: Tablet ne žvečite, sesajte ali drobite.
English: Your doctor will work out how much Iasibon you will be given depending on your illness.
Slovenian: Koliko zdravila vzeti Glede na vašo bolezen bo vaš zdravnik presodil, koliko zdravila Iasibon boste prejeli.
English: • dry mouth, strange taste in your mouth or difficulty swallowing
Slovenian: • suha usta, čuden okus v ustih ali težave pri požiranju, • anemija,
English: In the dose range recommended for treatment, the following response rates with the respective confidence intervals have been shown in clinical trials for patients with baseline albumin-corrected serum calcium ≥ 3.0 mmol/l after adequate rehydration.
Slovenian: V razponih odmerkov, priporočenih za zdravljenje, so med kliničnimi preskušanji za bolnike, ki so pred začetkom zdravljenja imeli korigirani kalcij v serumu ≥ 3,0 mmol/l po ustrezni rehidraciji,
English: Clinically relevant hypocalcaemia (very low serum calcium levels) should be corrected by intravenous administration of calcium gluconate.
Slovenian: Klinično pomembno hipokalciemijo (zelo nizke koncentracije kalcija v serumu) je treba popraviti z intravenskim dajanjem kalcijevega glukonata.
English: It is not known whether ibandronic acid is excreted in human milk.
Slovenian: Ni znano, ali se ibandronska kislina izloča v materino mleko.
English: Adverse effects of ibandronic acid in reproductive toxicity studies in the rat were those expected for this class of medicinal products (bisphosphonates).
Slovenian: Neželeni učinki ibandronske kisline v študijah vplivov na sposobnost za razmnoževanje pri podganah so bili pričakovano značilni za to vrsto zdravil (difosfonati).
English: = Serum calcium (mg/dl) + 0.8 x [4 - albumin (g/dl)]
Slovenian: = koncentracija kalcija v serumu (mg/dl) + 0,8 x [4albumin (g/dl)]
English: • flu-like symptoms, including fever, shaking and shivering, feeling of discomfort, fatigue, bone pain and aching muscles and joints.
Slovenian: • gripi podobni simptomi, vključno z zvišano telesno temperaturo, mrzlico in drgetanjem, občutjem nelagodja, utrujenostjo, bolečino v kosteh, mišicah in sklepih.
English: In healthy male volunteers and postmenopausal women, intravenous ranitidine caused an increase in ibandronic acid bioavailability of about 20% (which is within the normal variability of the bioavailability of ibandronic acid), probably as a result of reduced gastric acidity.
Slovenian: Antagonisti histaminskih receptorjev H2 in zaviralci protonske črpalke Pri zdravih moških prostovoljcih in ženskah v postmenopavzi je intravenski ranitidin povečal biološko uporabnost ibandronske kisline za 20 % (kar je znotraj normalne variabilnosti biološke uporabnosti ibandronske kisline).
English: No specific information is available on the treatment of overdosage with Iasibon.
Slovenian: Za ravnanje pri prevelikem odmerjanju z zdravilom Iasibon ni posebnih priporočil.
English: This is because Iasibon can affect the way some other medicines work.
Slovenian: Zdravilo Iasibon lahko vpliva na delovanje drugih zdravil.
English: No dose adjustment is necessary (see section 5.2).
Slovenian: Prilagajanje odmerkov ni potrebno (glejte poglavje 5.2).
English: Milk or antacids should be given to bind Iasibon.
Slovenian: Za vezavo zdravila Iasibon je treba zaužiti mleko ali antacide.
English: • a heart rhythm problem called ‘bundle branch block'
Slovenian: • težava s srčnim ritmom, imenovana »kračni blok«,
English: Iasibon therapy should only be initiated by physicians experienced in the treatment of cancer.
Slovenian: Zdravljenje z zdravilom Iasibon lahko začne le zdravnik, ki ima izkušnje z zdravljenjem raka.
English: Tests for genotoxicity revealed no evidence of genetic activity for ibandronic acid.
Slovenian: Študije genotoksičnosti niso pokazale genetske aktivnosti ibandronske kisline.
English: • your body temperature getting too low (‘hypothermia')
Slovenian: • prenizka telesna temperatura (hipotermija),
English: What you need to know before you take Iasibon.
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Iasibon
English: Protein binding in human plasma is approximately 87% at therapeutic concentrations, and thus interaction with other medicinal products, due to displacement is unlikely.
Slovenian: Vezava na plazemske beljakovine pri ljudeh je pri terapevtskih koncentracijah približno 87-%, zato so medsebojna delovanja z drugimi zdravili zaradi izpodrivanja malo verjetna.
English: 2 mg (2 ml of concentrate for solution for infusion)
Slovenian: 2 mg (2 ml koncentrata za raztopino za infundiranje)
English: A flu-like syndrome consisting of fever, chills, bone and/or muscle ache-like pain has occurred.
Slovenian: Pojavil se je gripi podobni sindrom, ki je vključeval vročino, mrzlico, bolečino v mišicah in/ali kosteh.
English: All Skeletal Related Events (SREs) Placebo n=158
Slovenian: Vsi z okostjem povezani dogodki (SREs) Placebo n = 158
English: The overall adverse event profile of ibandronic acid following the 15 minute infusion was consistent with the known safety profile over longer infusion times and no new safety concerns were identified relating to the use of a 15 minute infusion time.
Slovenian: Celoten profil neželenih dogodkov po 15 minutni infuziji je bil skladen z znanim varnostnim profilom pri daljši infuziji.
English: • pain or sore in your mouth or jaw.
Slovenian: • bolečina ali razjeda v vaših ustih ali čeljusti.
English: - Prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases
Slovenian: • preprečevanje z okostjem povezanih dogodkov (patološke frakture; zapleti, pri katerih je potrebno obsevanje ali kirurški poseg) pri bolnikih z rakom dojke in metastazami v kosteh,
English: You may have early signs of severe jaw problems (necrosis
Slovenian: Lahko imate zgodnje znake hudih težav s čeljustjo
English: Posology The recommended dose is one 50 mg film-coated tablet daily.
Slovenian: Priporočeni odmerek je ena 50 mg filmsko obložena tableta na dan.
English: A tabular summary of the secondary efficacy results is presented in Table 3.
Slovenian: Preglednica 3 nudi tabelaričen pregled sekundarnih rezultatov učinkovitosti.
English: No systemic accumulation was observed when ibandronic acid was administered intravenously once every 4 weeks for 48 weeks to patients with metastatic bone disease.
Slovenian: Po intravenskem dajanju ibandronske kisline enkrat na 4 tedne 48 tednov bolnikom z metastatično boleznijo kosti sistemske kumulacije niso opazili.
English: - Water is the only drink that should be taken with Iasibon.
Slovenian: - Vodaje edina tekočina, ki jo lahko bolnik zaužije z zdravilom Iasibon.
English: Patients with known hypersensitivity to other bisphosphonates Caution is to be taken in patients with known hypersensitivity to other bisphosphonates.
Slovenian: Bolniki z znano preobčutljivostjo za druge difosfonate Previdnost je potrebna pri bolnikih z znano preobčutljivostjo za druge difosfonate.
English: In reproductive studies in rats by the oral route, effects on fertility consisted of increased preimplantation losses at dose levels of 1 mg/kg/day and higher.
Slovenian: V študijah vplivov na sposobnost razmnoževanja pri podganah s peroralnim dajanjem je vpliv na plodnost predstavljala povečana izguba pred vgnezditvijo pri odmerkih 1 mg/kg/dan ali večjih.
English: This medicinal product does not require any special storage conditions prior to reconstitution.
Slovenian: Zdravilo pred rekonstitucijo ne potrebuje posebnih pogojev shranjevanja.
English: Frequency of administration
Slovenian: Pogostnost dajanja
English: Iasibon should not be used during breast-feeding.
Slovenian: Zdravila Iasibon se ne sme uporabljati med dojenjem.
English: Iasibon is used in adults and prescribed to you if you have breast cancer that has spread to your bones (called ‘bone metastases').
Slovenian: Zdravilo Iasibon uporabljamo pri odraslih in vam ga bodo predpisali, če imate raka dojke, ki se je razširil na kosti (metastaze v kosteh).
English: • tablet core: povidone, microcrystalline cellulose, crospovidone, maize starch pregelatinised,
Slovenian: • Jedro tablet: povidon, mikrokristalna celuloza, krospovidon, koruzni škrob (predgelirani), gliceroldibehenat, brezvodni koloidni silicijev dioksid.
English: For treatment of tumour induced hypercalcaemia, Iasibon concentrate for solution for infusion is generally given as a single infusion.
Slovenian: Za zdravljenje tumorsko povzročene hiperkalciemije običajno dajemo koncentrat za raztopino za infundiranje Iasibon kot enkratno infuzijo.
English: • The active substance is ibandronic acid.
Slovenian: • Zdravilna učinkovina je ibandronska kislina.
English: Bioavailability is reduced by about 90% when ibandronic acid is administered with a standard breakfast in comparison with bioavailability seen in fasted subjects.
Slovenian: Pri sočasnem jemanju ibandronske kisline s standardnim zajtrkom se biološka uporabnost zmanjša za okoli 90 % v primerjavi z biološko uporabnostjo, ki so jo opazili pri bolnikih po postu.
English: However, oral overdosage may result in upper gastrointestinal events, such as upset stomach, heartburn, oesophagitis, gastritis or ulcer.
Slovenian: Preveliko peroralno odmerjanje pa lahko povzroči neželene dogodke v zgornjem gastrointestinalnem traktu, kot so razdražen želodec, zgaga, ezofagitis, gastritis ali razjeda.
English: Prior to treatment with Iasibon the patient should be adequately rehydrated with 9 mg/ml (0.9%) sodium chloride solution.
Slovenian: Pred začetkom zdravljenja z zdravilom Iasibon je potrebna zadostna rehidracija bolnika z natrijevim kloridom 9 mg/ml (0,9 %).
English: Also some other medicines can affect the way Iasibon works.
Slovenian: Prav tako lahko druga zdravila vplivajo na delovanje zdravila Iasibon.
English: The median time to relapse (return of albumin-corrected serum calcium above 3.0 mmol/l) was 18 to 26 days.
Slovenian: Mediana časa do relapsa (ponovnega zvišanja korigiranega kalcija v serumu nad 3,0 mmol/l) je bila 18 do 26 dni.
English: ** Median change from baseline to last assessment
Slovenian: ** Mediana spremembe od začetne do zadnje ocene.
English: • flu-like symptoms, feeling generally unwell or in pain
Slovenian: • gripi podobni simptomi, občutek slabega počutja ali bolečine,
English: Iasibon concentrate for solution for infusion should be administered as an intravenous infusion over 2 hours.
Slovenian: Zdravilo Iasibon koncentrat za raztopino za infundiranje je treba aplicirati v obliki intravenske infuzije 2 uri.
English: Name and address of the manufacturers responsible for batch release
Slovenian: Ime in naslov izdelovalcev, odgovornih za sproščanje serije Koncentrat za raztopino za infundiranje
English: Special populations
Slovenian: Starejša populacija
English: Prior to treatment with Iasibon the patient should be adequately rehydrated with 9 mg/ml (0.9%) sodium chloride.
Slovenian: Pred zdravljenjem z zdravilom Iasibon izvedemo ustrezno hidracijo bolnika z raztopino natrijevega klorida 9 mg/ml (0,9-%).
English: (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare
Slovenian: (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), z neznano pogostnostjo (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
English: Albumin-corrected Serum calcium (mg/dl)
Slovenian: ali korigirani kalcij v serumu (mg/dl)
English: Pooled data from these studies demonstrated a significant advantage for Ibandronate 50 mg p.o. over placebo in the reduction in SREs measured by the SMPR (p=0.041).
Slovenian: Združeni podatki teh študij so pokazali značilno prednost ibandronske kisline (50 mg), dane peroralno, pred placebom v zmanjšanju SRE, ki so jih merili s SMPR (p = 0,041).
English: • Do not use this medicine after the expiry date which is stated on the folding box and on the label after EXP.
Slovenian: • Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
English: Iasibon contains lactose.
Slovenian: Zdravilo Iasibon vsebuje laktozo.
English: Drink a full glass of milk before you go. Do not make yourself sick.
Slovenian: Popijte poln kozarec mleka.
English: Paediatric population (see section 4.2 and section 5.1) There are no data on the use of Iasibon in patients less than 18 years old.
Slovenian: Pediatrična populacija (glejte poglavji 4.2 in 5.1) O uporabi zdravila Iasibon pri bolnikih, mlajših od 18 let, ni podatkov.